The University of Tokyo · Neuroscience
Professor Masanobu Kano's research lab specializes in the neurobiology of the endocannabinoid system, focusing on retrograde synaptic signaling and its role in synaptic plasticity within the central nervous system. The lab investigates the molecular and cellular mechanisms underlying endocannabinoid-mediated modulation of synaptic transmission, particularly in the hippocampus and cerebellum, with an emphasis on CB1 receptor function and the enzymatic regulation of endocannabinoid levels. Using electrophysiological, imaging, and genetic approaches in mouse models, the lab explores how endocannabinoids shape neural circuit development, function, and plasticity. Their work also extends to understanding the roles of key signaling molecules such as PLCβ4, Gq proteins, and monoacylglycerol lipase (MGL) in synaptic refinement and motor coordination.
Figures are computed from collected data and may differ slightly.
The discovery of cannabinoid receptors and subsequent identification of their endogenous ligands (endocannabinoids) in early 1990s have greatly accelerated research on cannabinoid actions in the brain. Then, the discovery in 2001 that endocannabinoids mediate retrograde synaptic signaling has opened up a new era for cannabinoid research and also established a new concept how diffusible messengers modulate synaptic efficacy and neural activity. The last 7 years have witnessed remarkable advances
Endocannabinoids work as retrograde messengers and contribute to short-term and long-term modulation of synaptic transmission via presynaptic cannabinoid receptors. It is generally accepted that the CB1 cannabinoid receptor (CB1) mediates the effects of endocannabinoid in inhibitory synapses. For excitatory synapses, however, contributions of CB1, "CB3," and some other unidentified receptors have been suggested. In the present study we used electrophysiological and immunohistochemical techniques
Endocannabinoids mediate retrograde signaling and modulate synaptic transmission in various regions of the CNS. Depolarization-induced elevation of intracellular Ca2+ concentration causes endocannabinoid-mediated suppression of excitatory/inhibitory synaptic transmission. Activation of G(q/11)-coupled receptors including group I metabotropic glutamate receptors (mGluRs) also causes endocannabinoid-mediated suppression of synaptic transmission. However, precise mechanisms of endocannabinoid produ
Marijuana affects neural functions through the binding of its active component (Δ 9 -THC) to cannabinoid receptors in the CNS. Recent studies have elucidated that endogenous ligands for cannabinoid receptors, endocannabinoids, serve as retrograde messengers at central synapses. Endocannabinoids are produced on demand in activity-dependent manners and released from postsynaptic neurons. The released endocannabinoids travel backward across the synapse, activate presynaptic CB1 cannabinoid receptor
Elimination of excess climbing fiber (CF)-Purkinje cell synapses during cerebellar development involves a signaling pathway that includes type 1 metabotropic glutamate receptor, Galphaq, and the gamma isoform of protein kinase C. To identify phospholipase C (PLC) isoforms involved in this process, we generated mice deficient in PLCbeta4, one of two major isoforms expressed in Purkinje cells. PLCbeta4 mutant mice are viable but exhibit locomotor ataxia. Their cerebellar histology, parallel fiber
Open papers in the app to read, cite, and organize with AI.
